Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IORT vs CCRT for Pancreatic Cancer
NCT02981641Unknown
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: Overall Survival at 3 years. Status: unknown.
Beyond the preview
Go deeper on NCT02981641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02981641.